An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Collaborative Insights to Solve the Puzzle of Bladder Cancer
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS, FASCO
Evan Y. Yu, MD
AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy
Charles Turck, PharmD, BCPS, BCCCP
Anthony Stein, MD
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Patient Perspectives on Bladder Cancer
Lillibeth Velasco, MSN, RN
Understanding the Expanding Role of Antibody-Drug Conjugates in Bladder Cancer
The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
Urvi A. Shah, MD, MS
A Patient-Centered Approach to Managing Anemia in Myelofibrosis
Brian P. McDonough, MD, FAAFP
John Mascarenhas, MD
Lucia Masarova, MD
Managing Anemia in Myelofibrosis: A Multidisciplinary Approach
Douglas Tremblay, MD
Marina Kremyanskaya, MD
Patient-Centered Insights for Advanced Prostate Cancer Treatment
Tanya Dorff, MD
Exercise in Multiple Myeloma: Balancing Benefits and Safety
Jens Hillengass, MD, PhD
Molecular Profiling for HER2+ Advanced Solid Tumors
Eric Van Cutsem, MD, PhD
David SP Tan, MBBS, PhD, PRCP
James Chih-Hsin Yang, MD, PhD
Kathleen Moore, MD, MS, FASCO
Advances in Prostate Cancer Care: Genetic Testing, Teamwork, and ARPIs
Neal Shore, MD
Chemotherapy Strategies for Metastatic PDAC
Efrat Dotan, MD
Shubham Pant, MD, MBBS
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Paolo Tarantino, MD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.